BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 29226159)

  • 1. Immunohistopathological Findings of Severe Cutaneous Adverse Drug Reactions.
    Orime M
    J Immunol Res; 2017; 2017():6928363. PubMed ID: 29226159
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recognition and Management of Severe Cutaneous Adverse Drug Reactions (Including Drug Reaction with Eosinophilia and Systemic Symptoms, Stevens-Johnson Syndrome, and Toxic Epidermal Necrolysis).
    Owen CE; Jones JM
    Med Clin North Am; 2021 Jul; 105(4):577-597. PubMed ID: 34059239
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatments for Severe Cutaneous Adverse Reactions.
    Cho YT; Chu CY
    J Immunol Res; 2017; 2017():1503709. PubMed ID: 29445753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Severe delayed skin reactions related to drugs in the paediatric age group: A review of the subject by way of three cases (Stevens-Johnson syndrome, toxic epidermal necrolysis and DRESS).
    Belver MT; Michavila A; Bobolea I; Feito M; Bellón T; Quirce S
    Allergol Immunopathol (Madr); 2016; 44(1):83-95. PubMed ID: 26089185
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The major SCAR syndromes].
    Piérard GE; Lesuisse M; Piérard-Franchimont C
    Rev Med Liege; 2017 Oct; 72(10):444-447. PubMed ID: 29058836
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Drug reaction with eosinophilia and systemic symptoms].
    Tehrany YA; Laffitte E; Grosgurin O; Spoerl D
    Rev Med Suisse; 2016 Apr; 12(513):684-6, 688-90. PubMed ID: 27197323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cicatrizing Conjunctivitis in a Patient Diagnosed With Drug Reaction With Eosinophilia and Systemic Symptoms/Drug-Induced Hypersensitivity Syndrome but With Features of Stevens-Johnson Syndrome.
    Bohm KJ; Ciralsky JB; Harp JL; Bajaj S; Sippel KC
    Cornea; 2016 Jun; 35(6):888-91. PubMed ID: 27078005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Severe Cutaneous Adverse Drug Reactions in Pediatric Patients: A Multicenter Study.
    Dibek Misirlioglu E; Guvenir H; Bahceci S; Haktanir Abul M; Can D; Usta Guc BE; Erkocoğlu M; Toyran M; Nacaroglu HT; Civelek E; Buyuktiryaki B; Ginis T; Orhan F; Kocabas CN
    J Allergy Clin Immunol Pract; 2017; 5(3):757-763. PubMed ID: 28351788
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histopathological study of six types of adverse cutaneous drug reactions using granulysin expression.
    Weinborn M; Barbaud A; Truchetet F; Beurey P; Germain L; Cribier B
    Int J Dermatol; 2016 Nov; 55(11):1225-1233. PubMed ID: 27421110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated serum osteopontin levels in patients with severe cutaneous adverse drug reactions.
    Suzuki M; Koshikawa S; Watanabe H; Inomata N; Yamaguchi Y; Aihara M; Sueki H
    J Dermatol; 2023 Apr; 50(4):536-540. PubMed ID: 36540013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemokines in Severe Cutaneous Adverse Reactions (SCARs).
    Miyagawa F; Asada H
    Biomolecules; 2021 Jun; 11(6):. PubMed ID: 34204146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Paracetamol (Acetaminophen)-associated SJS, TEN, AGEP, and DRESS Syndromes - A Narrative Review.
    Pakkir Maideen NM; Barakat IR; Jumale AH
    Curr Drug Saf; 2024; 19(2):218-223. PubMed ID: 37151075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Severe flucloxacillin-induced acute generalized exanthematous pustulosis (AGEP), with toxic epidermal necrolysis (TEN)-like features: does overlap between AGEP and TEN exist? Clinical report and review of the literature.
    van Hattem S; Beerthuizen GI; Kardaun SH
    Br J Dermatol; 2014 Dec; 171(6):1539-45. PubMed ID: 24888401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fever, rash, and systemic symptoms: understanding the role of virus and HLA in severe cutaneous drug allergy.
    Pavlos R; Mallal S; Ostrov D; Pompeu Y; Phillips E
    J Allergy Clin Immunol Pract; 2014; 2(1):21-33. PubMed ID: 24565765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [DRUG INDUCED EXANTHEMA AND SEVERE CUTANEOUS DRUG REACTIONS].
    Bensaïd B; Valeyrie-Allanore L; Lebrun-Vignes B; Nicolas JF
    Rev Prat; 2015 Sep; 65(7):981-5. PubMed ID: 26619740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential diagnosis of severe cutaneous drug eruptions.
    Bachot N; Roujeau JC
    Am J Clin Dermatol; 2003; 4(8):561-72. PubMed ID: 12862499
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Severe Drug Hypersensitivity Reactions: Clinical Pattern, Diagnosis, Etiology and Therapeutic Options.
    Paulmann M; Mockenhaupt M
    Curr Pharm Des; 2016; 22(45):6852-6861. PubMed ID: 27779083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Severe Cutaneous Drug Reactions: Do Overlapping Forms Exist?
    Horcajada-Reales C; Pulido-Pérez A; Suárez-Fernández R
    Actas Dermosifiliogr; 2016; 107(1):23-33. PubMed ID: 26520037
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute generalized exanthematous pustulosis and Stevens-Johnson syndrome overlap due to hydroxychloroquine: a case report.
    Coleman I; Ruiz G; Brahmbhatt S; Ackerman L
    J Med Case Rep; 2020 Nov; 14(1):210. PubMed ID: 33138853
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stevens-Johnson syndrome and toxic epidermal necrolysis due to anticonvulsants share certain clinical and laboratory features with drug-induced hypersensitivity syndrome, despite differences in cutaneous presentations.
    Teraki Y; Shibuya M; Izaki S
    Clin Exp Dermatol; 2010 Oct; 35(7):723-8. PubMed ID: 19874350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.